These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 8129381)

  • 41. Randomized trials of induction chemotherapy. A critical review.
    Forastiere AA
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):725-36. PubMed ID: 1890063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy for head and neck cancer.
    Tannock IF
    J Otolaryngol; 1984 Apr; 13(2):99-104. PubMed ID: 6202878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
    Inuyama Y; Fukuda S; Horiuchi M
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chemotherapy of advanced head and neck tumors. A prospective randomized study comparing the effectiveness of chemotherapy alone to a chemo-radiotherapy procedure].
    Klima A; von Ilberg C; Klippstein T; Szepesi S
    Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):205-10. PubMed ID: 2439861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant carboplatin & 5 fluorouracil combination chemotherapy and radiotherapy in the treatment of locally advanced head and neck cancer: primary report.
    Tepmongkol P; Panichevalux A; Skulchan V; Thanaphum V; Sangruchi S; Thansakul A; Jirapanuwat S
    J Med Assoc Thai; 1991 Dec; 74(12):658-68. PubMed ID: 1813592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction chemotherapy for head and neck cancer: recent data.
    Vokes EE
    Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy for head and neck cancer: progress and controversy in the management of patients with M0 disease.
    Clark JR; Frei E
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):44-57. PubMed ID: 2669137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of cis-platinum and 5-fluorouracil as induction chemotherapy prior to radiation therapy in advanced head and neck cancer.
    Thongprasert S; Lorvidhaya V; Sumitsawan Y; Tonusin A; Phandphae P; Changwaiwit W; Chaimongkol B
    J Med Assoc Thai; 1988 Nov; 71(11):602-4. PubMed ID: 3221145
    [No Abstract]   [Full Text] [Related]  

  • 49. Cisplatin combinations in the treatment of head and neck cancer.
    al-Sarraf M
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):28-34. PubMed ID: 7992064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
    von Heyden HW; Schröder M; Scherpe A; Stennert E; Beyer JH; Nagel GA; Hoffmann H; Schneider B
    HNO; 1984 Nov; 32(11):454-9. PubMed ID: 6210278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Locally advanced head and neck cancer: combined chemotherapy and radical radiation therapy for organ and function preservation (interim report).
    Cheung AY; Rinehart J; Ruff T
    Radiology; 1997 Jul; 204(1):207-10. PubMed ID: 9205248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Advances in the treatment of head and neck tumors. I. Chemotherapy].
    Stupp R; Vokes EE
    Strahlenther Onkol; 1995 Jan; 171(1):12-7. PubMed ID: 7839300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Multidisciplinary treatment for organ/function preservation in head and neck cancer].
    Inuyama Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):396-402. PubMed ID: 7927168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of radio- and chemotherapy on survival in advanced head and neck tumors].
    Klima A; von Ilberg C; Bergmann L; Klippstein T; Zoubek A; Mitrou PS; Szepisi S; Jakobi A
    Strahlenther Onkol; 1987 May; 163(5):297-300. PubMed ID: 3296260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TPF: a rational choice for larynx preservation?
    Calais G
    Oncologist; 2010; 15 Suppl 3():19-24. PubMed ID: 21036885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The promise of biochemical modulation in combined modality therapy.
    Vokes EE
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):29-33. PubMed ID: 7527598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neo-adjuvant chemotherapy in patients with head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1905-11. PubMed ID: 7487119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controversies in the multimodality management of head and neck cancer.
    Thomas CR; Taylor SG
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):769-81. PubMed ID: 1890066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Organ preservation in multimodality therapy of head and neck cancer.
    Urba S; Wolf GT
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):713-24. PubMed ID: 1890062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
    Clark JR; Busse PM; Norris CM; Andersen JW; Dreyfuss AI; Rossi RM; Poulin MD; Colevas AD; Tishler RB; Costello R; Lucarini JW; Lucarini D; Thornhill L; Lackey M; Peters E; Posner MR
    J Clin Oncol; 1997 Sep; 15(9):3100-10. PubMed ID: 9294473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.